Shocking development of the electroconvulsive therapy device market

Electroconvulsive Therapy Devices Market Worth $18.79 Million by 2031 – Exclusive Report by InsightAce Analytic Pvt. Sp. z o. o

InsightAce Analitics Pvt. Ltd. announces the publication of a market assessment report on “Global Electroconvulsive Therapy Devices Market – (By Туре (Unіlаtеrаl, Віlаtеrаl), by End User (Ноѕріtаlѕ, Ѕресіаltу Сlіnісѕ, М еntаl Ноѕріtаlѕ, Other)), Trends, Competition analysis in the industry, Revenues and forecast until 2031

According to the latest research by InsightAce Analytic, the global electroconvulsive therapy device market is valued at USD 16.12 million in 2023 and is expected to reach USD 18.79 million by 2031, at a CAGR of 2.01% in forecast period 2024-2031.

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/2361

As mental illnesses have become more common and electroconvulsive therapy (ECT) has gained greater acceptance as a legitimate treatment option, the ECT market has grown significantly in recent years. Patients and doctors continue to prefer ECT because it produces better therapeutic results than other therapeutic techniques. Electroconvulsive therapy (ECT) is a medical procedure that deliberately uses small electrical currents to produce a short-lived attack.

ECT is often used as a last resort to treat severe depression, bipolar disorder, and other mental illnesses when medications or psychotherapy are not helpful. Muscle relaxants are used under general anesthesia to prevent convulsions during the procedure. Despite previous debate and stigma, modern ECT is safe, well-regulated, and often provides rapid symptom relief when other therapies have failed.

The exact mechanism by which ECT improves mental illness is unknown. However, it is thought to involve a complex cascade of neurochemical reactions that ultimately reset specific brain circuits.

List of prominent players in the electroconvulsive therapy device market

• Somatic Limited Liability Company
• Abbot
• Soterix Medical Inc
• Mecta Corporation
• Ectron Ltd.
• Other notable players

Market dynamics:

Drivers-
The main factor driving the electroconvulsive treatment market is the growing incidence of mental illnesses. One of the significant key factors driving the growth of the global electroconvulsive treatment market is the rising incidence of mental illnesses, including depression, schizophrenia, and others. The incidence of mental illness has increased over the past decade and is exacerbated by rising levels of stress, social isolation and other socioeconomic problems.

An additional significant factor driving the global electroconvulsive therapy market is the growing use of ECT. In the past, ECT was only used as a last option for patients with severe, unresponsive depression. ECT is widely used to treat many diseases such as schizophrenia, bipolar disorder, catatonia and serious neurological conditions including Parkinson’s disease.

Challenges:
Important growth factors hindering the global electroconvulsive treatment (ECT) market are the potential for cognitive impairment after ECT. After receiving ECT, problems with concentration, memory, thinking and reasoning are referred to as cognitive impairment. After electroconvulsive therapy (ECT), patients often experience some degree of memory loss, especially retrograde amnesia, which worsens pre-treatment memories.

The risks associated with general anesthesia used in ECT are comparable to those associated with other anesthetic procedures. On the day of treatment, the most common side effects of ECT are nausea, headaches, exhaustion, confusion, and mild memory loss. These effects may last for minutes or hours.

Regional trends:
The United States is one of the major revenue generating countries in North America and will continue to play a large role in the global electroconvulsive therapy market. One of the main drivers of growth in this area is the high incidence of mental illness. ECT therapy is becoming an increasingly popular and effective treatment method due to its increasing acceptance, the development of short pulse therapy devices and the implantation of single-sided electrodes.

Are you curious about the latest version of the report? Inquiry before purchasing: https://www.insightaceanalytic.com/enquiry-before-buying/2361

Segmentation of the electroconvulsive therapy device market –

By type-
• One-sided
• Double-sided
By end user-
• Hospitals
• Specialized clinics
• Psychiatric hospitals
• Others

By region-
North America-
• United States
• Canada
• Mexico

Europe-
• Germany
• Great Britain
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia-Pacific

Latin America-
• Brazil
• Argentina
• Rest of Latin America

Middle East and Africa-
• GCC countries
• South Africa
• Rest of the Middle East and Africa

For more personalization @ https://www.insightaceanalytic.com/customisation/2361

Contact us:
InsightAce Analitics Pvt. Sp. z o. o
Tel.: +1 718 593 4405
E-mail: [email protected]
Site visit: www.insightaceanalytic.com
Follow us on LinkedIn @ bit.ly/2tBXsgS
Follow us on Facebook @ bit.ly/2H9jnDZ

About us:
InsightAce Analytic is a market research and consulting company that empowers clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to grow businesses.
We help clients gain competitive advantage by identifying untapped markets, discovering new and competitive technologies, segmenting potential markets and repositioning products.
Our specialty is delivering syndicated and custom market intelligence reports with in-depth analysis containing key market insights in a timely and cost-effective manner.

This release was published on openPR.